banner
Inquiry

Liposomes

Cat. No. Product Name Inquiry
X26-05-ZQ2880 Terpenes-incorporated indomethacin liposome gels
X26-05-ZQ2881 Galactosylated cholesterol ligand-modified norcantharidin liposomes
X26-05-ZQ2882 Ultrasound-mediated iRGD-targeted drug-loaded liposome-microbubble complexes (iRGD-LMC)
X26-05-ZQ2883 Novel Ganoderma applanatum polysaccharide-loaded long-circulating thermosensitive liposome-C3H8 microbubbles
X26-05-ZQ2884 Sodium diclofenac calcium acetate gradient liposomes
X26-05-ZQ2885 Compound clindamycin phosphate liposome gels
X26-05-ZQ2886 RB/rhodamine B-labeled dermatan sulfate oligosaccharide-loaded liposomes
X26-05-ZQ2887 Doxorubicin/epalrestat co-loaded targeted liposomes
X26-05-ZQ2888 Cholic acid-baicalin liposomes
X26-05-ZQ2889 Ketoprofen ethosome gels
X26-05-ZQ2890 Aminopterin APGA targeting molecule-modified artemether liposomes
X26-05-ZQ2891 Flurbiprofen liposome gels
X26-05-ZQ2892 Liposomal doxorubicin protoporphyrin for laser confocal cell imaging
X26-05-ZQ2893 Fluorescein isothiocyanate-labeled cellulose octacetate-loaded liposomes
X26-05-ZQ2894 Doxorubicin and siRNA co-loaded cationic liposomes
X26-05-ZQ2895 Hyaluronic acid-targeted chlorogenic acid liposomes
X26-05-ZQ2896 c(RGD)fk-mediated doxorubicin-dihydroartemisinin nanoparticle liposomes
X26-05-ZQ2897 ICG-labeled cellobiose-loaded liposomes
X26-05-ZQ2898 Raltitrexed pH-sensitive liposomes
X26-05-ZQ2899 Nimesulide liposome gels
X26-05-ZQ2900 6-Carboxymethylfluorescein-labeled lysozyme-loaded liposomes
X26-05-ZQ2901 Cell-penetrating peptide (TAT)-modified paclitaxel/tamoxifen co-loaded liposomes
X26-05-ZQ2902 Liposome-encapsulated mesoporous polydopamine co-loaded with doxorubicin and allicin
X26-05-ZQ2903 Doxorubicin propylene glycol liposomes
X26-05-ZQ2904 Resveratrol dipalmitoylphosphatidylcholine (DPPC) liposomes
X26-05-ZQ2905 Pentapeptide YIGSR-modified doxorubicin-5F liposomes
X26-05-ZQ2906 Melatonin-loaded liposomes
X26-05-ZQ2907 Liposome-encapsulated mesoporous polydopamine
X26-05-ZQ2908 Nucleic acid-loaded liposomes
X26-05-ZQ2909 IR783 and DOX co-encapsulated liposomes
X26-05-ZQ2910 mRNA-loaded liposomes
X26-05-ZQ2911 Cationic liposomes loaded with siRNA & DIR
X26-05-ZQ2912 R8 peptide-modified epirubicin and dihydroartemisinin co-loaded liposomes
X26-05-ZQ2913 CLPVASC+CY5-liposomes
X26-05-ZQ2914 Albendazole-encapsulated liposomes
X26-05-ZQ2915 Breviscapine pronominal nanoliposomes
X26-05-ZQ2916 Liver-targeted bovine serum albumin (BSA) liposomes
X26-05-ZQ2917 Hepatocyte glycyrrhetinic acid surface-modified liver-targeted liposomes
X26-05-ZQ2918 Bulleyaconitine A multivesicular liposome-modified polylactic acid micelle composites
X26-05-ZQ2919 O-Trimethyl chitosan-coated doxorubicin liposomes

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.